Achillion Pharmaceuticals, Inc. (ACHN) Tops Q1 EPS by 2c

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $1.06 million.

For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Owlet (OWLT) Tops Q2 EPS by 9c
• Borr Drilling (BORR) Misses Q2 EPS by 69c